Figure 1. Outcomes of Beta Blocker Use Before Bypass Surgery

Skip Navigation

U.S. Department of Health and Human Services

Search www.ahrq.gov

E-mail Updates

You Are Here: AHRQ Home > News & Information > Fact Sheets > Improving Health Care Quality

Figure 1. Outcomes of Beta Blocker Use Before Bypass Surgery

With beta blockers, the 30-day mortality rate was 2.8%; without beta blockers, the 30-day mortality rate was 3.4%.

Source: Ferguson, Coombs, and Peterson. Preoperative b-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287(17):2221-7.

Return to Document

Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364